Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its innovative medicines and cell therapy businesses, which will result in the loss of around 300 jobs or ...

The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...

Developing new drugs and therapies is a contact sport for research sites. Investigators are on the frontlines, meeting and ...

Sword Health, a digital therapeutics company that started in the physical therapy space, has acquired digital mental health ...

Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity ...

US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of commissioner ...

Cambridge, UK-based Neurocrine Biosciences - partnered with Japan’s Nxera Pharma - has announced it has received IND ...

The US FDA has green lit ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment of HIV-1 in children weighing at least ...

Europe. Whilst long recognised as Europe's largest partnering conference, it's now expanding to become the continent's most ...

Jazz Pharmaceuticals has been granted US approval for two combinations of its cancer drug Ziihera for people with advanced ...

Pharmaceutical portfolio decision-making is facing structural pressure. Patent expirations, rising development costs, ...

CHB is a major public health challenge and a leading cause of liver cancer globally. Chronic hepatitis B occurs when the ...